Skip to main content
Equibles
XBIO logo

XBIO · Xenetic Biosciences, Inc. · Metrics

Track XBIO — free

Use XBIO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research XBIO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.20 -0.04 (-1.79%) At close · Oct 5
Rebalance outlook locked
Market Cap
$5.60M
Shares
2.34M
Volume · Oct 5 9535 Avg daily vol (3M) 88.1K

XBIO metrics

57 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.24
Market cap
$5.60M

Price action

20 metrics
Price change (1W)
-6.3%
Price change (30D)
-47.7%
Price change (3M)
-19.1%
Price change (6M)
-25.6%
Price change (YTD)
+3.2%
Price change (1Y)
-31.9%
Trailing year
Price change (5Y)
—
52-week high
$10.36
52-week low
$2.02
Change from 52-week high
-78.4%
Change from 52-week low
+10.9%
Annualized volatility
174.1%
Annualized volatility (3M)
124.4%
Beta
2.2
RSI (14D)
34.8
Price vs SMA 50
-30.4%
Price vs SMA 200
-21.5%
Avg volume (3M)
88,098
Relative volume
0.5
Average dollar volume
$249,002

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
2.34M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.7×
reciprocal yield 58.2%
P / book
0.9
reciprocal yield 108.4%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-44.2%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
-81.0%
Trailing 12 months
Net margin
-75.9%
Gross profit (TTM)
$0
Operating profit (TTM)
−$2.64M
Net income (TTM)
−$2.48M
Trailing 12 months
Diluted EPS (TTM)
$-1.15
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$3.23

Growth

11 metrics
Revenue growth YoY
+12.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$3.26M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+48.8%
Year over year · more shares
Revenue CAGR (3Y)
+20.4%
Revenue CAGR (5Y)
+46.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-40.8%
Return on assets
-35.5%
Debt / equity
—
Current ratio
7.4
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
7.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$6.47M
Total assets
$6.97M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$2.31M
Capital expenditures (TTM)
$0
R&D (TTM)
$2.74M
SG&A (TTM)
—
Stock compensation (TTM)
$93,129
R&D / revenue
84.1%
Stock compensation / revenue
2.9%

Ownership (13F)

3 metrics
13F filers
8
13F filer change QoQ
+2
Institutional ownership
6.5%

Short interest

3 metrics
Short interest
1.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
34 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1534525 CUSIP 984015602 Visit website Investor relations